Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mycosis Fungoides (MF)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658924
What this trial is testing

Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-Cell LymphomaMycosis Fungoides (MF)
Peking University First Hospital 35
Testing effectiveness (Phase 2)Temporarily pausedNCT05138458
What this trial is testing

MT-101 in Subjects With CD5+ Relapsed/Refractory TCL

Who this might be right for
Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousMycosis Fungoides+2 more
Myeloid Therapeutics 40
Early research (Phase 1)Temporarily pausedNCT05414500
What this trial is testing

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

Who this might be right for
Cutaneous T Cell LymphomaMycosis Fungoides
University of Alabama at Birmingham 10
Testing effectiveness (Phase 2)Ended earlyNCT03837457
What this trial is testing

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study

Who this might be right for
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
miRagen Therapeutics, Inc. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03385226
What this trial is testing

A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)

Who this might be right for
Cutaneous T Cell LymphomaMycosis Fungoides/Sezary Syndrome
University College, London 46
Not applicableWithdrawnNCT02301494
What this trial is testing

Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma

Who this might be right for
Mycosis Fungoides
Rochester General Hospital
Testing effectiveness (Phase 2)Ended earlyNCT02341209
What this trial is testing

Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-cell LymphomaMycosis FungoidesSezary Syndrome
Rochester General Hospital 1
Early research (Phase 1)WithdrawnNCT03617224
What this trial is testing

Pembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary Syndrome

Who this might be right for
Cutaneous T-Cell Lymphomas
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT06149247
What this trial is testing

HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Who this might be right for
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Soligenix 10
Not applicableStudy completedNCT05455931
What this trial is testing

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

Who this might be right for
Mycosis Fungoides and Sézary Syndrome
Kyowa Kirin Pharmaceutical Development Ltd 73
Testing effectiveness (Phase 2)Looking for participantsNCT04256018
What this trial is testing

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

Who this might be right for
Sezary SyndromeMycosis Fungoides
Stanford University 30
Testing effectiveness (Phase 2)Ended earlyNCT04218825
What this trial is testing

REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)

Who this might be right for
Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
European Organisation for Research and Treatment of Cancer - EORTC 2
Early research (Phase 1)UnknownNCT04118868
What this trial is testing

Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

Who this might be right for
Mycosis Fungoides
Sorrento Therapeutics, Inc. 10
Large-scale testing (Phase 3)Ended earlyNCT02811783
What this trial is testing

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Who this might be right for
Mycosis FungoidesLymphoma, T-Cell, CutaneousSézary Syndrome
Elorac, Inc. 59
Not applicableNot Yet RecruitingNCT07795242
What this trial is testing

AI in MF Diagnosis

Who this might be right for
Mycosis Fungoides of Skin (Diagnosis)Artificial Intelligence (AI) in Diagnosis
Al-Azhar University 50
Early research (Phase 1)Study completedNCT02580552
What this trial is testing

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Who this might be right for
Cutaneous T-cell Lymphoma (CTCL)Mycosis Fungoides (MF)Chronic Lymphocytic Leukemia (CLL)+2 more
miRagen Therapeutics, Inc. 66